The three patient community representatives who will be members of the NECST Network Strategic Governance Committee are:
Following a national call out for nominations to these positions, the Committee voted to appoint these three representatives from a pool of 20 nominations.
The NECST Network has submitted an application to become a full member of the Australian Clinical Trials Alliance (ACTA). ACTA is the national peak advisory body that was formed to advance the common and shared interests of clinical trials networks, clinical trial coordinating centres and clinical quality registries across discipline and disease boundaries. Their mission is to promote effective and cost-effective healthcare in Australia through investigator-initiated clinical trials and clinical quality registries that generate evidence to support decisions made by health practitioners, policymakers and consumers.
The NECST Network is keen to be informed of any trials occurring in the area of endometriosis. Help in recruitment of participants will be offered through Jean Hailes social media posts if appropriate and included in NECST Network updates to keep the community of researchers, clinicians and others interested in endometriosis research informed. Please email Rachel Mudge [email protected] with details of your trial and evidence of ethics approval.
The University of Tasmania is conducting research into the effectiveness of cognitive behavioural therapy (CBT) and mindfulness in managing the distress and pain of endometriosis. Women around Australia diagnosed with endometriosis are invited to take part in this free eight-session trial. To find out more about the treatment, contact Dr Leesa Van Niekerk on (03) 6226 6645 or [email protected]
The first progress report was submitted in January to the Australian Government for the MRFF NECST Network Grant. Following is an excerpt from the report detailing the activities completed during the reporting period (1 June 2018 – 31 December 2018) and outcomes:
The NECST Network has been in the establishment phase during this reporting period. The first milestone (1), "Establishment of the Clinical Trials Network (CTN)", was defined as being achieved when scientific and clinical research communities with interest, experience and expertise relevant to endometriosis have established a research network and facilitated the necessary infrastructure to support national multi-centre trials. We are tracking well with this milestone, however it will now likely be completed by 30/06/19.
As defined in the project management outline in our MRFF grant application, the goals for the establishment phase are:
The outcomes achieved to date are:
Progress against Milestone (2), "Collection of baseline data on burden of disease", has commenced. Dr Ingrid Rowlands has started analysis to in order to identify the prevalence and incidence of endometriosis according to the ALSWH.
Progress against Milestone (3), "Establishment of the core national patient database and clinical sample repository", has begun. The set-up of the database and repository is a complex task with many stakeholders with multiple ethics, procedure and process issues involved. Working groups consisting of expert clinicians and scientists are being established to reach a consensus regarding best practice for the framework and network of NECST. These groups will meet in Quarter 2 of 2019 to determine best practice resulting in establishment of the framework and network after consultation with experts in the field.